Showing results (111-120 of 119) with videos related to
Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 119 results.
European Journal of Gastroenterology & Hepatology|February 3, 2000
IOIBD questionnaire on the clinical use of azathioprine, 6-mercaptopurine, cyclosporin A and methotrexate in the treatment of inflammatory bowel diseasesS G Meuwissen, K Ewe, M A Gassull, et al.Gut|June 20, 2001
Interleukin 10 (Tenovil) in the prevention of postoperative recurrence of Crohn's diseaseJ F Colombel, P Rutgeerts, H Malchow, et al.Acta Oncologica (Stockholm, Sweden)|January 1, 1990
Current status of epirubicin (Farmorubicin) in the treatment of solid tumoursH T Mouridsen, C Alfthan, L Bastholt, et al.British Medical Journal|September 24, 1977
Cimetidine in patients with gastric ulcer: a multicentre controlled trialF Frost, I Rahbek, S J Rune, et al.Cancer Chemotherapy and Pharmacology|January 1, 1991
Multiple-dose pharmacokinetics of epirubicin at four different dose levels: studies in patients with metastatic breast cancerP Jakobsen, E Steiness, L Bastholt, et al.Cancer Chemotherapy and Pharmacology|January 1, 1991
A randomized study of epirubicin at four different dose levels in advanced breast cancer. Feasibility of myelotoxicity prediction through single blood-sample measurementP Jakobsen, L Bastholt, M Dalmark, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1996
Modulation of high-dose infusional fluorouracil by low-dose methotrexate in patients with advanced or metastatic colorectal cancer: final results of a randomized European Organization for Research and Treatment of Cancer StudyG Blijham, T Wagener, J Wils, et al.Scandinavian Journal of Gastroenterology|December 1, 2000
Eradication of Helicobacter pylori compared with long-term acid suppression in duodenal ulcer disease. A randomized trial with 2-year follow-up. The Danish Ulcer Study GroupP Bytzer, C Aalykke, S Rune, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1996
Dose-response relationship of epirubicin in the treatment of postmenopausal patients with metastatic breast cancer: a randomized study of epirubicin at four different dose levels performed by the Danish Breast Cancer Cooperative GroupL Bastholt, M Dalmark, S B Gjedde, et al.Pageof 12